Baran Ersoy, PhD

Highlights

1
Hepatology (Baltimore, Md.) · 2020
BEBaran Ersoy
PMID: 32498134DOISenior author27 citations

25

2 grants

KP
Leveraging the Gut Microbiome to Regulate Hepatic Gluconeogenesis
National Institute of Diabetes and Digestive and Kidney Diseases · 2022–2027
K08DK129867-01A1
PI
Thioesterase-mediated lipotoxicity in liver and thermogenic adipose tissue
National Institute of Diabetes and Digestive and Kidney Diseases · 2021–2027
R01DK129576-05

Completed grants (4)

MPI
Them1 Inhibitors for the Management of Non-Alcoholic Fatty Liver Disease
National Institute of Diabetes and Digestive and Kidney Diseases · 2023–2025 · via The Brigham & Women's Hospital INC
R01DK133988-03
PI
Acot9 Promotes Lipotoxicity
National Institute of Diabetes and Digestive and Kidney Diseases · 2019–2021
R03DK117247-02
PI
Membrane-Based Mechanisms of Hepatic Insulin Resistance
National Institute of Diabetes and Digestive and Kidney Diseases · 2016–2019Career
K01DK102733-03
PI
Regulation of Hepatic Glucose Homeostasis by Phosphatidylcholine Transfer Protein
NIDDK · 2011–2013 · via NIH RePORTER
F32DK093195-02